Distinct metabolic network states manifest in the gene expression profiles of pediatric inflammatory bowel disease patients and controls

Information on biological networks can greatly facilitate the function-orientated interpretation of high-throughput molecular data. Genome-wide metabolic network models of human cells, in particular, can be employed to contextualize gene expression profiles of patients with the goal of both, a better understanding of individual etiologies and an educated reclassification of (clinically defined) phenotypes. We analyzed publicly available expression profiles of intestinal tissues from treatment-naive pediatric inflammatory bowel disease (IBD) patients and age-matched control individuals, using a reaction-centric metabolic network derived from the Recon2 model. By way of defining a measure of ‘coherence’, we quantified how well individual patterns of expression changes matched the metabolic network. We observed a bimodal distribution of metabolic network coherence in both patients and controls, albeit at notably different mixture probabilities. Multidimensional scaling analysis revealed a bisectional pattern as well that overlapped widely with the metabolic network-based results. Expression differences driving the observed bimodality were related to cellular transport of thiamine and bile acid metabolism, thereby highlighting the crosstalk between metabolism and other vital pathways. We demonstrated how classical data mining and network analysis can jointly identify biologically meaningful patterns in gene expression data.

[1]  P. Rutgeerts,et al.  Role of genetics in prediction of disease course and response to therapy. , 2010, World journal of gastroenterology.

[2]  M. Dubinsky Special issues in pediatric inflammatory bowel disease. , 2008, World journal of gastroenterology.

[3]  B. Palsson,et al.  Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110 , 1994, Applied and environmental microbiology.

[4]  C. Fiocchi,et al.  Inflammatory Bowel Disease-Associated Gene Expression in Intestinal Epithelial Cells by Differential cDNA Screening and mRNA Display , 2003, Inflammatory bowel diseases.

[5]  Marc-Thorsten Hütt,et al.  Understanding genetic variation - the value of systems biology. , 2014, British journal of clinical pharmacology.

[6]  A. Barabasi,et al.  The network takeover , 2011, Nature Physics.

[7]  Mario Albrecht,et al.  Genetics of Crohn disease, an archetypal inflammatory barrier disease , 2005, Nature Reviews Genetics.

[8]  T. Langmann,et al.  Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. , 2006, Biochimica et biophysica acta.

[9]  D. Saunders,et al.  Metabolism of chenodeoxycholate by intestinal mucosa. , 1976, Gastroenterology.

[10]  C. Gille,et al.  HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology , 2010, Molecular systems biology.

[11]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[12]  Thomas Lengauer,et al.  Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA Microarrays , 2005, PLoS medicine.

[13]  B. Palsson,et al.  Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Timothy L. Tickle,et al.  Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.

[15]  S. Matern,et al.  Hepatic and extrahepatic glucuronidation of bile acids in man. Characterization of bile acid uridine 5'-diphosphate-glucuronosyltransferase in hepatic, renal, and intestinal microsomes. , 1984, The Journal of clinical investigation.

[16]  Marc-Thorsten Hütt,et al.  Analog regulation of metabolic demand , 2011, BMC Systems Biology.

[17]  B. Palsson,et al.  In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data , 2001, Nature Biotechnology.

[18]  O. Demin,et al.  The Edinburgh human metabolic network reconstruction and its functional analysis , 2007, Molecular systems biology.

[19]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[20]  B. Palsson,et al.  Genome-scale models of microbial cells: evaluating the consequences of constraints , 2004, Nature Reviews Microbiology.

[21]  J. Hampe,et al.  IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans[S] , 2015, Journal of Lipid Research.

[22]  H. Said,et al.  Association of TM4SF4 with the Human Thiamine Transporter-2 in Intestinal Epithelial Cells , 2014, Digestive Diseases and Sciences.

[23]  W. Roediger,et al.  THE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE? , 1980, The Lancet.

[24]  Kenneth J. Kauffman,et al.  Advances in flux balance analysis. , 2003, Current opinion in biotechnology.

[25]  F. Hampel The Breakdown Points of the Mean Combined With Some Rejection Rules , 1985 .

[26]  T. Ideker,et al.  Differential network biology , 2012, Molecular systems biology.

[27]  E. Ruppin,et al.  Reconstruction of Arabidopsis metabolic network models accounting for subcellular compartmentalization and tissue-specificity , 2011, Proceedings of the National Academy of Sciences.

[28]  E. Ruppin,et al.  Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism , 2010, Molecular systems biology.

[29]  A. K. Hansen,et al.  High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis. , 2015, Journal of Crohn's & colitis.

[30]  Peter Kraft,et al.  Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. , 2016, Gastroenterology.

[31]  Marc-Thorsten Hütt,et al.  A network perspective on metabolic inconsistency , 2012, BMC Systems Biology.

[32]  S. Ben-Shachar,et al.  Gene Expression Profiles of Ileal Inflammatory Bowel Disease Correlate with Disease Phenotype and Advance Understanding of Its Immunopathogenesis , 2013, Inflammatory bowel diseases.

[33]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[34]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.